Results 91 to 100 of about 80,890 (284)

Aging Is a Key Driver for Adult Acute Myeloid Leukemia

open access: yesAging and Cancer, EarlyView.
Acute myeloid leukemia (AML) is a classical age‐related hematologic malignancy, and a key driver of AML is aging, which profoundly regulates intrinsic factors such as genomic instability, epigenetic reprogramming, and metabolic dysregulation, and alters bone marrow microenvironment.
Rong Yin, Haojian Zhang
wiley   +1 more source

Zero-sum problems and coverings by proper cosets

open access: yes, 2003
Let G be a finite Abelian group and D(G) its Davenport constant, which is defined as the maximal length of a minimal zero-sum sequence in G. We show that various problems on zero-sum sequences in G may be interpreted as certain covering problems.
Gao, Weidong, Geroldinger, Alfred
core   +1 more source

Mutant NPM1 in Acute Myeloid Leukemia Initiation and Maintenance

open access: yesAging and Cancer, EarlyView.
NPM1 mutations drive acute myeloid leukemia by acting as neomorphic transcriptional regulators that cooperate with Menin–MLL and XPO1 to sustain HOX/MEIS1 expression and block differentiation. Targeting these mutant‐specific transcriptional dependencies provides a rational therapeutic strategy for NPM1‐mutated AML.
Yanan Jiang   +3 more
wiley   +1 more source

Clinical Spectrum and Outcomes of SOX1 Antibody‐Associated Paraneoplastic Neurological Syndromes: A Chinese Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background SOX1 antibody‐positive paraneoplastic neurological syndromes (PNS) exhibit significant population‐specific clinical heterogeneity. While Western cohorts predominantly manifest Lambert‐Eaton myasthenic syndrome (65%–80%), comprehensive clinical characterization and treatment response data in Asian populations remain critically ...
Jin‐Long Ye   +11 more
wiley   +1 more source

Subsequence Sums of Zero-sum free Sequences II

open access: yesArs Comb., 2009
Let $G$ be a finite abelian group, and let $S$ be a sequence over $G$. Let $f(S)$ denote the number of elements in $G$ which can be expressed as the sum over a nonempty subsequence of $S$. In this paper, we determine all the sequences $S$ that contains no zero-sum subsequences and $f(S)\leq 2|S|-1$.
openaire   +2 more sources

Topological methods in zero-sum Ramsey theory

open access: yes, 2023
A cornerstone result of Erd\H os, Ginzburg, and Ziv (EGZ) states that any sequence of $2n-1$ elements in $\mathbb{Z}/n$ contains a zero-sum subsequence of length $n$.
Wellner, Zoe   +7 more
core  

Clustering Algorithm Reveals Dopamine‐Motor Mismatch in Cognitively Preserved Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the relationship between dopaminergic denervation and motor impairment in two de novo Parkinson's disease (PD) cohorts. Methods n = 249 PD patients from Parkinson's Progression Markers Initiative (PPMI) and n = 84 from an external clinical cohort.
Rachele Malito   +14 more
wiley   +1 more source

A Multistrategy Improved Archimedes Optimization Algorithm for Solving Engineering Problems

open access: yesJournal of Mathematics
Given the shortcomings of the Archimedes optimization algorithm (AOA), the traditional AOA exhibits the following limitations: the initialization phase employs a uniform 0-1 random number distribution to generate sequences, resulting in limited diversity
Xiaoping Xu   +5 more
doaj   +1 more source

Ramsey theory, Discrepancy Theory, Zero-Sums and Symmetric Functions

open access: yes, 2020
The underlying philosophy of Ramsey Theory is that total disorder is impossible, and the underlying philosophy of Discrepancy Theory is that a totally equal distribution is impossible.
Bialostocki, Arie
core  

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy